Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pharmasset Inc (VRUS) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pharmasset Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1301081.
Total stock buying since 2010: $0.
Total stock sales since 2010: $32,171,642.
Total stock option exercises since 2010: $3,657,496.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2011 | 0 | $0 | 339,319 | $31,549,412 | 297,320 | $2,549,574 |
| 2010 | 0 | $0 | 20,787 | $622,230 | 112,791 | $1,107,922 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2011-12 | 0 | $0 | 6,252 | $814,823 | 6,252 | $55,205 |
| 2011-11 | 0 | $0 | 20,624 | $1,537,725 | 20,624 | $210,877 |
| 2011-10 | 0 | $0 | 40,000 | $3,173,320 | 40,000 | $60,000 |
| 2011-09 | 0 | $0 | 43,124 | $2,830,055 | 43,124 | $93,817 |
| 2011-07 | 0 | $0 | 20,938 | $2,314,216 | 20,938 | $77,446 |
| 2011-06 | 0 | $0 | 20,000 | $2,010,700 | 20,000 | $60,000 |
| 2011-05 | 0 | $0 | 102,499 | $10,497,721 | 70,000 | $900,800 |
| 2011-04 | 0 | $0 | 79,603 | $7,968,996 | 70,103 | $1,005,596 |
| 2011-03 | 0 | $0 | 6,279 | $401,856 | 6,279 | $85,833 |
| 2010-12 | 0 | $0 | 0 | $0 | 43,125 | $799,106 |
| 2010-10 | 0 | $0 | 5,000 | $147,500 | 0 | $0 |
| 2010-09 | 0 | $0 | 12,811 | $377,924 | 62,477 | $279,917 |
| 2010-07 | 0 | $0 | 0 | $0 | 7,189 | $28,899 |
| 2010-06 | 0 | $0 | 2,976 | $96,806 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-12-01 | Berrey M Michelle (Chief Medical Officer) | Sale | 6,252 | 130.33 | 814,823 |
| 2011-12-01 | Berrey M Michelle (Chief Medical Officer) | Option Ex | 6,252 | 8.83 | 55,205 |
| 2011-11-01 | Berrey M Michelle (Chief Medical Officer) | Sale | 3,124 | 74.56 | 232,925 |
| 2011-11-01 | Berrey M Michelle (Chief Medical Officer) | Option Ex | 3,124 | 6.83 | 21,352 |
| 2011-11-01 | Otto Michael J. (Chief Scientific Officer) | Sale | 17,500 | 74.56 | 1,304,800 |
| 2011-11-01 | Otto Michael J. (Chief Scientific Officer) | Option Ex | 17,500 | 10.83 | 189,525 |
| 2011-10-03 | Price P Schaefer (President & CEO) | Sale | 40,000 | 79.33 | 3,173,320 |
| 2011-10-03 | Price P Schaefer (President & CEO) | Option Ex | 40,000 | 1.50 | 60,000 |
| 2011-09-01 | Price P Schaefer (President and CEO) | Sale | 40,000 | 65.63 | 2,625,040 |
| 2011-09-01 | Price P Schaefer (President and CEO) | Option Ex | 40,000 | 1.50 | 60,000 |
| 2011-09-01 | Berrey M Michelle (Chief Medical Officer) | Sale | 3,124 | 65.63 | 205,015 |
| 2011-09-01 | Berrey M Michelle (Chief Medical Officer) | Option Ex | 3,124 | 10.82 | 33,817 |
| 2011-07-01 | Price P Schaefer (President and CEO) | Sale | 20,000 | 110.47 | 2,209,320 |
| 2011-07-01 | Price P Schaefer (President and CEO) | Option Ex | 20,000 | 3.00 | 60,000 |
| 2011-07-01 | Berrey M Michelle (Chief Medical Officer) | Sale | 938 | 111.83 | 104,896 |
| 2011-07-01 | Berrey M Michelle (Chief Medical Officer) | Option Ex | 938 | 18.60 | 17,446 |
| 2011-06-01 | Price P Schaefer (President and CEO) | Sale | 20,000 | 100.53 | 2,010,700 |
| 2011-06-01 | Price P Schaefer (President and CEO) | Option Ex | 20,000 | 3.00 | 60,000 |
| 2011-05-09 | Rogers Michael D. (Chief Development Officer) | Sale | 10,000 | 109.08 | 1,090,800 |
| 2011-05-09 | Rogers Michael D. (Chief Development Officer) | Option Ex | 10,000 | 13.88 | 138,800 |
| 2011-05-06 | Williamson Robert F Iii (Director) | Sale | 31,666 | 104.36 | 3,304,600 |
| 2011-05-06 | Williamson Robert F Iii (Director) | Option Ex | 20,000 | 3.00 | 60,000 |
| 2011-05-06 | Leutzinger Kurt (Chief Financial Officer) | Sale | 11,287 | 102.88 | 1,161,206 |
| 2011-05-05 | Leutzinger Kurt (Chief Financial Officer) | Sale | 9,546 | 102.61 | 979,515 |
| 2011-05-03 | Conrad Herbert J (Director) | Sale | 40,000 | 99.04 | 3,961,600 |
| 2011-05-03 | Conrad Herbert J (Director) | Option Ex | 40,000 | 17.55 | 702,000 |
| 2011-04-28 | Otto Michael J. (Chief Scientific Officer) | Sale | 9,500 | 99.85 | 948,575 |
| 2011-04-27 | Rogers Michael D. (Chief Development Officer) | Sale | 20,000 | 99.00 | 1,980,060 |
| 2011-04-27 | Rogers Michael D. (Chief Development Officer) | Option Ex | 20,000 | 13.88 | 277,600 |
| 2011-04-27 | Berrey M Michelle (Chief Medical Officer) | Sale | 50,103 | 100.60 | 5,040,361 |
| 2011-04-27 | Berrey M Michelle (Chief Medical Officer) | Option Ex | 50,103 | 14.53 | 727,996 |
| 2011-03-22 | Otto Michael J. (Chief Scientific Officer) | Sale | 6,279 | 64.00 | 401,856 |
| 2011-03-22 | Otto Michael J. (Chief Scientific Officer) | Option Ex | 6,279 | 13.67 | 85,833 |
| 2010-12-20 | Hahn Elliot F (Director) | Option Ex | 43,125 | 18.53 | 799,106 |
| 2010-10-01 | Otto Michael J. (Chief Scientific Officer) | Sale | 5,000 | 29.50 | 147,500 |
| 2010-09-30 | Hahn Elliot F (Director) | Option Ex | 24,666 | 3.69 | 91,017 |
| 2010-09-28 | Otto Michael J. (Chief Scientific Officer) | Sale | 12,811 | 29.50 | 377,924 |
| 2010-09-28 | Otto Michael J. (Chief Scientific Officer) | Option Ex | 7,811 | 4.02 | 31,400 |
| 2010-09-17 | Hahn Elliot F (Director) | Option Ex | 30,000 | 5.25 | 157,500 |
| 2010-07-01 | Otto Michael J. (Chief Scientific Officer) | Option Ex | 7,189 | 4.02 | 28,899 |
| 2010-06-17 | Berrey M Michelle (Chief Medical Officer) | Sale | 2,976 | 32.53 | 96,806 |
Insider trading activities including stock purchases, stock sales, and option exercises of VRUS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pharmasset Inc (symbol VRUS, CIK number 1301081) see the Securities and Exchange Commission (SEC) website.